Literature DB >> 10203737

The diagnosis and treatment of osteoporosis: future prospects.

D J Baylink1, D D Strong, S Mohan.   

Abstract

Osteoporosis is a common disease that affects millions of patients throughout the world. We anticipate that both the diagnosis and the treatment of this disease will be revolutionized by the integration of genomics and informatics. It is predicted that a genetic algorithm will be developed to identify at-risk patients before they develop osteoporosis, so that preventive measures can be instituted. The sequencing of the human genome will lead to revolutionary advances in at least three areas of osteoporosis therapy: small molecule therapy, protein therapy and gene therapy. One area of focus for future therapeutics in osteoporosis will be on osteogenic agents, which should have a high likelihood of success because the skeleton has the innate capacity to regenerate itself.

Entities:  

Mesh:

Year:  1999        PMID: 10203737     DOI: 10.1016/s1357-4310(98)01426-9

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  3 in total

1.  Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice.

Authors:  Yuji Kasukawa; David J Baylink; Rongqing Guo; Subburaman Mohan
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

2.  Mandibular Trabecular Bone Analysis Using Local Binary Pattern for Osteoporosis Diagnosis.

Authors:  L Khojastepour; M Hasani; M Ghasemi; A R Mehdizadeh; F Tajeripour
Journal:  J Biomed Phys Eng       Date:  2019-02-01

Review 3.  Role of prolyl hydroxylase domain proteins in bone metabolism.

Authors:  David Wolf; Aruljothi Muralidharan; Subburaman Mohan
Journal:  Osteoporos Sarcopenia       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.